You have 9 free searches left this month | for more free features.

sage-217

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDD Trial (SAGE-217)

Not yet recruiting
  • Major Depressive Disorder
  • SAGE-217
  • (no location specified)
Dec 9, 2022

MDD, Insomnia Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Insomnia
  • SAGE-217
  • Placebo
  • Little Rock, Arkansas
  • +27 more
Oct 13, 2022

Bipolar Disorder I, Bipolar Disorder II, Major Depressive Episode Trial in United States (SAGE-217, Placebo)

Completed
  • Bipolar Disorder I
  • +2 more
  • SAGE-217
  • Placebo
  • Little Rock, Arkansas
  • +10 more
Mar 23, 2022

Parkinson Disease Trial in United States (SAGE-217, Levodopa, Antiparkinsonian Agent(s))

Completed
  • Parkinson Disease
  • SAGE-217
  • +2 more
  • Panorama City, California
  • +10 more
Jan 20, 2022

MDD Trial in United States (SAGE-217, Placebo)

Completed
  • Major Depressive Disorder
  • SAGE-217
  • Placebo
  • Rogers, Arkansas
  • +52 more
Nov 22, 2022

Major Depression Trial in United States (SAGE-217, Placebo)

Completed
  • Major Depression
  • SAGE-217
  • Placebo
  • Garden Grove, California
  • +7 more
Jan 20, 2022

Essential Tremor Trial in United States (SAGE-217, Placebo)

Completed
  • Essential Tremor
  • SAGE-217
  • Placebo
  • Anniston, Alabama
  • +25 more
Jan 20, 2022

Depressive Disorder, Major Trial in United States (SAGE-217, Placebo)

Completed
  • Depressive Disorder, Major
  • SAGE-217
  • Placebo
  • Rogers, Arkansas
  • +37 more
Mar 25, 2022

Depressive Disorder, Major Trial in United States (SAGE-217, Matching Placebo, Sertraline)

Completed
  • Depressive Disorder, Major
  • SAGE-217
  • +6 more
  • Dothan, Alabama
  • +50 more
Feb 28, 2022

MDD Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • SAGE-217
  • Placebo
  • Bentonville, Arkansas
  • +45 more
Oct 15, 2021